Western blot analysis revealed that HD treatment (6 and 12 mg/kg) significantly elevated HNF-1β protein expression levels (Figures 6A, B) compared with the model group, a result corroborated by immunohistochemistry (Figure 6G). The gene discussed is HNF1B; the disease is Huntington disease.